Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study

Saved in:
Bibliographic Details
Published in:Acta ophthalmologica (Oxford, England) England), 2015-08, Vol.93 (5), p.e400-e402
Main Authors: Januschowski, Kai, Dimopoulos, Spyridon, Szurman, Peter, Feltgen, Nicolas, Spitzer, Bernhard, Pielen, Amelie, Rehak, Matus, Spital, Georg, Meyer, Carsten H., Szurman, Gesine B.
Format: Article
Language:English
Subjects:
Angiogenesis Inhibitors - administration & dosage
Bevacizumab - administration & dosage
Humans
Intravitreal Injections
Macular Edema - drug therapy
Macular Edema - etiology
Retinal Vein Occlusion - complications
Retreatment
Retrospective Studies
Vascular Endothelial Growth Factor A - antagonists & inhibitors
Visual Acuity - drug effects
Visual Acuity - physiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4580-6e6837b32b0fc8f79712ef68f943c3f70e93df1ec3c429694bfa5e20c592de493
cites cdi_FETCH-LOGICAL-c4580-6e6837b32b0fc8f79712ef68f943c3f70e93df1ec3c429694bfa5e20c592de493
container_end_page e402
container_issue 5
container_start_page e400
container_title Acta ophthalmologica (Oxford, England)
container_volume 93
creator Januschowski, Kai
Dimopoulos, Spyridon
Szurman, Peter
Feltgen, Nicolas
Spitzer, Bernhard
Pielen, Amelie
Rehak, Matus
Spital, Georg
Meyer, Carsten H.
Szurman, Gesine B.
description
doi_str_mv 10.1111/aos.12600
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1697968418</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3750909681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4580-6e6837b32b0fc8f79712ef68f943c3f70e93df1ec3c429694bfa5e20c592de493</originalsourceid><addsrcrecordid>eNp1kMlKBDEQhoMoLqMHX0ACnjy0Jr2kO95kcANhDip4a9LpCmbo7oxZRtqH8JnNLHqzLlUUX_0JH0KnlFzSWFfCuEuaMkJ20CEtiyLJSlbt_s3F2wE6cm5OCKOM5fvoIC0Y5axKD9H34zAH6bUZsJPv0ANWxmI9eCuW2lsQHW5gKaT-Cr1osH8HKxbjGuqFDJ2w2EALvcBtAOwNlrC67bAFr4fYl6AHbKTsgouPXMe9C5132CgscB9HvboAi50P7XiM9pToHJxs-wS93t2-TB-Sp9n94_TmKZF5UZGEAauyssnShihZqZKXNAXFKsXzTGaqJMCzVlGQmcxTznjeKFFASmTB0xZynk3Q-SZ3Yc1HAOfruQk2_tfVlPEyuslpFamLDSWtcc6CqhdW98KONSX1ynwdzddr85E92yaGpof2j_xVHYGrDfCpOxj_T6pvZs-byB_3nJBJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1697968418</pqid></control><display><type>article</type><title>Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study</title><source>Wiley</source><creator>Januschowski, Kai ; Dimopoulos, Spyridon ; Szurman, Peter ; Feltgen, Nicolas ; Spitzer, Bernhard ; Pielen, Amelie ; Rehak, Matus ; Spital, Georg ; Meyer, Carsten H. ; Szurman, Gesine B.</creator><creatorcontrib>Januschowski, Kai ; Dimopoulos, Spyridon ; Szurman, Peter ; Feltgen, Nicolas ; Spitzer, Bernhard ; Pielen, Amelie ; Rehak, Matus ; Spital, Georg ; Meyer, Carsten H. ; Szurman, Gesine B. ; Bevacizumab Study Group Venous Occlusion ; Bevacizumab Study Group Venous Occlusion</creatorcontrib><identifier>ISSN: 1755-375X</identifier><identifier>EISSN: 1755-3768</identifier><identifier>DOI: 10.1111/aos.12600</identifier><identifier>PMID: 25619682</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Angiogenesis Inhibitors - administration &amp; dosage ; Bevacizumab - administration &amp; dosage ; Humans ; Intravitreal Injections ; Macular Edema - drug therapy ; Macular Edema - etiology ; Retinal Vein Occlusion - complications ; Retreatment ; Retrospective Studies ; Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors ; Visual Acuity - drug effects ; Visual Acuity - physiology</subject><ispartof>Acta ophthalmologica (Oxford, England), 2015-08, Vol.93 (5), p.e400-e402</ispartof><rights>2015 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd</rights><rights>Copyright © 2015 Acta Ophthalmologica Scandinavica Foundation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4580-6e6837b32b0fc8f79712ef68f943c3f70e93df1ec3c429694bfa5e20c592de493</citedby><cites>FETCH-LOGICAL-c4580-6e6837b32b0fc8f79712ef68f943c3f70e93df1ec3c429694bfa5e20c592de493</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25619682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Januschowski, Kai</creatorcontrib><creatorcontrib>Dimopoulos, Spyridon</creatorcontrib><creatorcontrib>Szurman, Peter</creatorcontrib><creatorcontrib>Feltgen, Nicolas</creatorcontrib><creatorcontrib>Spitzer, Bernhard</creatorcontrib><creatorcontrib>Pielen, Amelie</creatorcontrib><creatorcontrib>Rehak, Matus</creatorcontrib><creatorcontrib>Spital, Georg</creatorcontrib><creatorcontrib>Meyer, Carsten H.</creatorcontrib><creatorcontrib>Szurman, Gesine B.</creatorcontrib><creatorcontrib>Bevacizumab Study Group Venous Occlusion</creatorcontrib><creatorcontrib>Bevacizumab Study Group Venous Occlusion</creatorcontrib><title>Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study</title><title>Acta ophthalmologica (Oxford, England)</title><addtitle>Acta Ophthalmol</addtitle><subject>Angiogenesis Inhibitors - administration &amp; dosage</subject><subject>Bevacizumab - administration &amp; dosage</subject><subject>Humans</subject><subject>Intravitreal Injections</subject><subject>Macular Edema - drug therapy</subject><subject>Macular Edema - etiology</subject><subject>Retinal Vein Occlusion - complications</subject><subject>Retreatment</subject><subject>Retrospective Studies</subject><subject>Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors</subject><subject>Visual Acuity - drug effects</subject><subject>Visual Acuity - physiology</subject><issn>1755-375X</issn><issn>1755-3768</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kMlKBDEQhoMoLqMHX0ACnjy0Jr2kO95kcANhDip4a9LpCmbo7oxZRtqH8JnNLHqzLlUUX_0JH0KnlFzSWFfCuEuaMkJ20CEtiyLJSlbt_s3F2wE6cm5OCKOM5fvoIC0Y5axKD9H34zAH6bUZsJPv0ANWxmI9eCuW2lsQHW5gKaT-Cr1osH8HKxbjGuqFDJ2w2EALvcBtAOwNlrC67bAFr4fYl6AHbKTsgouPXMe9C5132CgscB9HvboAi50P7XiM9pToHJxs-wS93t2-TB-Sp9n94_TmKZF5UZGEAauyssnShihZqZKXNAXFKsXzTGaqJMCzVlGQmcxTznjeKFFASmTB0xZynk3Q-SZ3Yc1HAOfruQk2_tfVlPEyuslpFamLDSWtcc6CqhdW98KONSX1ynwdzddr85E92yaGpof2j_xVHYGrDfCpOxj_T6pvZs-byB_3nJBJ</recordid><startdate>201508</startdate><enddate>201508</enddate><creator>Januschowski, Kai</creator><creator>Dimopoulos, Spyridon</creator><creator>Szurman, Peter</creator><creator>Feltgen, Nicolas</creator><creator>Spitzer, Bernhard</creator><creator>Pielen, Amelie</creator><creator>Rehak, Matus</creator><creator>Spital, Georg</creator><creator>Meyer, Carsten H.</creator><creator>Szurman, Gesine B.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>201508</creationdate><title>Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study</title><author>Januschowski, Kai ; Dimopoulos, Spyridon ; Szurman, Peter ; Feltgen, Nicolas ; Spitzer, Bernhard ; Pielen, Amelie ; Rehak, Matus ; Spital, Georg ; Meyer, Carsten H. ; Szurman, Gesine B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4580-6e6837b32b0fc8f79712ef68f943c3f70e93df1ec3c429694bfa5e20c592de493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Angiogenesis Inhibitors - administration &amp; dosage</topic><topic>Bevacizumab - administration &amp; dosage</topic><topic>Humans</topic><topic>Intravitreal Injections</topic><topic>Macular Edema - drug therapy</topic><topic>Macular Edema - etiology</topic><topic>Retinal Vein Occlusion - complications</topic><topic>Retreatment</topic><topic>Retrospective Studies</topic><topic>Vascular Endothelial Growth Factor A - antagonists &amp; inhibitors</topic><topic>Visual Acuity - drug effects</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Januschowski, Kai</creatorcontrib><creatorcontrib>Dimopoulos, Spyridon</creatorcontrib><creatorcontrib>Szurman, Peter</creatorcontrib><creatorcontrib>Feltgen, Nicolas</creatorcontrib><creatorcontrib>Spitzer, Bernhard</creatorcontrib><creatorcontrib>Pielen, Amelie</creatorcontrib><creatorcontrib>Rehak, Matus</creatorcontrib><creatorcontrib>Spital, Georg</creatorcontrib><creatorcontrib>Meyer, Carsten H.</creatorcontrib><creatorcontrib>Szurman, Gesine B.</creatorcontrib><creatorcontrib>Bevacizumab Study Group Venous Occlusion</creatorcontrib><creatorcontrib>Bevacizumab Study Group Venous Occlusion</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Acta ophthalmologica (Oxford, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Januschowski, Kai</au><au>Dimopoulos, Spyridon</au><au>Szurman, Peter</au><au>Feltgen, Nicolas</au><au>Spitzer, Bernhard</au><au>Pielen, Amelie</au><au>Rehak, Matus</au><au>Spital, Georg</au><au>Meyer, Carsten H.</au><au>Szurman, Gesine B.</au><aucorp>Bevacizumab Study Group Venous Occlusion</aucorp><aucorp>Bevacizumab Study Group Venous Occlusion</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study</atitle><jtitle>Acta ophthalmologica (Oxford, England)</jtitle><addtitle>Acta Ophthalmol</addtitle><date>2015-08</date><risdate>2015</risdate><volume>93</volume><issue>5</issue><spage>e400</spage><epage>e402</epage><pages>e400-e402</pages><issn>1755-375X</issn><eissn>1755-3768</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>25619682</pmid><doi>10.1111/aos.12600</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1755-375X
ispartof Acta ophthalmologica (Oxford, England), 2015-08, Vol.93 (5), p.e400-e402
issn 1755-375X
1755-3768
language eng
recordid cdi_proquest_journals_1697968418
source Wiley
subjects Angiogenesis Inhibitors - administration & dosage
Bevacizumab - administration & dosage
Humans
Intravitreal Injections
Macular Edema - drug therapy
Macular Edema - etiology
Retinal Vein Occlusion - complications
Retreatment
Retrospective Studies
Vascular Endothelial Growth Factor A - antagonists & inhibitors
Visual Acuity - drug effects
Visual Acuity - physiology
title Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A15%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Injection%20scheme%20for%20intravitreal%20bevacizumab%20therapy%20for%20macular%20oedema%20due%20to%20central%20retinal%20vein%20occlusion:%20results%20of%20a%20multicenter%20study&rft.jtitle=Acta%20ophthalmologica%20(Oxford,%20England)&rft.au=Januschowski,%20Kai&rft.aucorp=Bevacizumab%20Study%20Group%20Venous%20Occlusion&rft.date=2015-08&rft.volume=93&rft.issue=5&rft.spage=e400&rft.epage=e402&rft.pages=e400-e402&rft.issn=1755-375X&rft.eissn=1755-3768&rft_id=info:doi/10.1111/aos.12600&rft_dat=%3Cproquest_cross%3E3750909681%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4580-6e6837b32b0fc8f79712ef68f943c3f70e93df1ec3c429694bfa5e20c592de493%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1697968418&rft_id=info:pmid/25619682&rfr_iscdi=true